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Antifungal azoles inhibit ergosterol biosynthesis by interfering with lanosterol 14α-
demethylase. In this study, seven upregulated and four downregulated ergosterol biosyn-
thesis genes in response to ketoconazole treatment were identified in Neurospora crassa.
Azole sensitivity test of knockout mutants for six ketoconazole-upregulated genes in ergos-
terol biosynthesis revealed that deletion of only sterol C-22 desaturase ERG5 altered
sensitivity to azoles: the erg5 mutant was hypersensitive to azoles but had no obvious
defects in growth and development.The erg5 mutant accumulated higher levels of ergosta
5,7-dienol relative to the wild type but its levels of 14α-methylated sterols were similar to
the wild type. ERG5 homologs are highly conserved in fungal kingdom. Deletion of Fusar-
ium verticillioides erg5 also increased ketoconazole sensitivity, suggesting that the roles of
ERG5 homologs in azole resistance are highly conserved among different fungal species,
and inhibition of ERG5 could reduce the usage of azoles and thus provide a new target for
drug design.
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INTRODUCTION
Antifungal azoles are the most commonly used drugs for con-
trolling fungal infections. Azoles inhibit ergosterol biosynthesis
by disrupting essential P450 superfamily protein lanosterol 14α-
demethylase CYP51 (syn. ERG11) (Bossche et al., 1984; Kelly et al.,
1993). In addition, the inhibition of lanosterol 14α-demethylase
also results in the accumulation of the toxic 14-α methylated
sterols, like 14α-methyl-ergosta-8,24(28)-dien-3β,6α-diol (Kelly
et al., 1995). Incorporation of such compounds into fungal
membranes reduces their rigidity (Abe et al., 2009).
Biological processes of sterol biosynthesis are highly conserved
in fungal kingdom (Ferreira et al., 2005). In response to azole
treatments, significant transcriptional increases in several genes
involved in ergosterol biosynthesis, such as ERG2 (C-8 sterol iso-
merase), ERG3 (C-5 sterol desaturase), ERG5 (C-22 sterol desat-
urase), ERG6 (C-24 sterol methyltransferase), ERG25 (C-4 methyl
sterol oxidase), and ERG11, are consistently observed in many fun-
gal species such as Saccharomyces cerevisiae (Bammert and Fostel,
2000; Agarwal et al., 2003), Candida albicans (De Backer et al.,
2001; Liu et al., 2005), Aspergillus fumigatus (da Silva Ferreira et al.,
2006), Trichophyton rubrum (Yu et al., 2007), Cryptococcus neofor-
mans (Florio et al., 2011), and Fusarium graminearum (Liu et al.,
2010; Becher et al., 2011). Many reports have shown that increased
expression of ERG11 could reduce azole susceptibility (Hamamoto
et al., 2000; Schnabel and Jones, 2001; Du et al., 2004; Ma et al.,
2006). In addition to ERG11, ERG3, and ERG5 have also been
shown to be related to drug susceptibility. Many ERG3 mutants of
S. cerevisiae or C. albicans with defects in C5-6 desaturase showed
increased resistance to azoles (Watson et al., 1989; Martel et al.,
2010a; Morio et al., 2012; Vale-Silva et al., 2012). A clinical isolate
of C. albicans with mutations in both ERG11 and ERG5 is cross
resistance to azoles and amphotericin B (Martel et al., 2010b).
However, due to lack of systemic analysis, except ERG11, contri-
butions of most of these azole-responsive genes to azole resistance
were not fully understood.
Since the non-pathogenic Neurospora crassa has less redun-
dant genes in ergosterol biosynthesis relative to other filamentous
pathogenic fungi and has knockout mutants available for most of
ergosterol synthesis genes, it can be an excellent model for systemic
analysis of the contributions of these azole-responsive genes to
azole resistance. In this study, we demonstrate that ERG5 mediates
the sensitivity to antifungal azoles in both N. crassa and Fusarium
verticillioides.
MATERIALS AND METHODS
STRAINS AND CULTURE CONDITIONS
Neurospora crassa strains used in this study are listed in Table 1.
All of them were obtained from the Fungal Genetics Stock Center1
(University of Kansas Medical Center). Vogel’s minimum medium
(Vogel, 1956), supplemented with 2% (w/v) sucrose for slants
or 2% glucose for plates and the liquid medium, was used for
1www.fgsc.net
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Table 1 | Neurospora strains used in this study.
Strain Genotype
FGSC#4200 Wild type, a
FGSC#18507 erg2 (NCU04156), a, hetero
FGSC#13802 erg5 (NCU05278), a
FGSC#13803 erg5 (NCU05278), A
FGSC#12752 erg6 (NCU03006), a
FGSC#12753 erg6 (NCU03006), A
FGSC#18506 erg24 (NCU08762), a, hetero
FGSC#17674 erg25 (NCU06402), a
culturing strains. All cultures were grown at 28˚C in the light.
Antifungal compounds were added as needed.
DRUG SUSCEPTIBILITY TEST
Ketoconazole, fluconazole, and itraconazole were dissolved in
dimethyl sulfoxide (DMSO) and then aseptically added to the
autoclaved medium before making agar plates. The final concen-
trations of ketoconazole, fluconazole, and itraconazole in the agar
plates were 2, 25, and 10µg/ml, respectively. The final DMSO
concentration was below 0.25% (v/v). Two microliters of conidial
suspension were inoculated on plates (Φ= 9 cm) with or without
antifungal drugs and incubated at 28˚C for 66 h.
MIC DETERMINATION OF KETOCONAZOLE, ITRACONAZOLE, AND
FLUCONAZOLE
The MICs of three azoles for each strain were determined in
96-well microtiter plate according to National Committee for
Clinical Laboratory Standards (CLSI, 2008). Briefly, 100µl of 2×
azole solution and 100µl of conidial suspension were added into
each well. The final conidial concentration was approximately
1× 106 conidia/ml. The plates were incubated at 28˚C for 24 h.
The MIC was determined as the lowest drug concentration without
growth.
RNA EXTRACTION AND DIGITAL GENE EXPRESSION PROFILING
ANALYSIS
The transcriptional responses of ergosterol biosynthesis genes to
ketoconazole treatment in the wild-type strain were detected by
digital gene expression (DGE) profiling (Nielsen et al., 2006).
Briefly, conidia of the wild-type strain was inoculated into 20-
ml liquid medium in a plate (Φ= 9 cm) and incubated for
24 h at 28˚C in darkness to form mycelial mat on the sur-
face of the liquid medium. Mycelial mat then was cut into
small pieces (Φ= 10 mm) and transferred to the liquid medium
(2 pieces/100 ml). Cultures were incubated at 28˚C with shak-
ing at 180 rpm for 12 h. Ketoconazole was then added into
the medium to reach a final concentration of 2.5µg/ml. After
24 h of incubation, mycelia were harvested and total RNA was
extracted and subjected to DGE analysis as described by Sun et al.
(2011).
STEROL EXTRACTION AND ANALYSIS
Sterols of dried mycelium (0.3 g) was extracted into 1.5-ml
chloroform under ultrasonication for 12 h. The extracts were
dried and subsequently dissolved into 150µl methanol under
ultrasonication for 1 h. After filtration with a Millipore filter,
the extracts were subjected to HPLC-MS analysis following the
method reported by Cañabate-Díaz et al. (2007) with some
modifications.
Liquid chromatography separation was performed on an Agi-
lent Zorbax Extend-C18 1.8µm 2.1 mm× 50 mm column using
an Agilent 1200 Series system (Agilent, USA). Total flow rate was
0.4 ml min−1; mobile phase A consisted of water with 0.01% acetic
acid and mobile phase B consisted of acetonitrile. Total elution
program was 27 min. Gradient began with 70% mobile phase B,
changed to 100% B over 2 min, maintained a constant level from 2
to 18 min at 100% B and then decreased to 70% B over 1 min prior
to re-stabilization over 8 min before the next injection. The col-
umn temperature was maintained at 40˚C. The injection volume
was 10µl.
Mass spectra were acquired with an Agilent Accurate-Mass-
Q-TOF MS 6520 system. Analytes were detected in the positive
ionization mode with an APCI probe. For Q-TOF/MS conditions,
fragmentor and capillary voltages were kept at 130 and 3500 V,
respectively. Nitrogen was supplied as the nebulizing and drying
gas. Temperature of the drying gas and vaporizer were both set at
350˚C. The corona was set to 4µA. The flow rate of the drying
gas and the pressure of the nebulizer were 3 l min−1 and 50 psi,
respectively. Full-scan spectra were acquired over a scan range of
m/z 80–1000 at 1.03 spectra s−1. The derived sterols were identi-
fied with reference molecular weight and fragmentation spectra
for known standards.
PHYLOGENETIC ANALYSIS
Protein sequences were aligned with the Clustal X 2.1 software
(Larkin et al., 2007). Then, the neighbor-joining (NJ) tree was
constructed using MEGA 5 software (Tamura et al., 2011). To
assess the confidence of phylogenetic relationships, the bootstrap
tests were conducted with 1000 resamplings.
KNOCKOUT OF erg5 HOMOLOG GENE IN FUSARIUM VERTICILLIOIDES
In order to knockout erg5 homologous genes (erg5A:
FVEG_07284; erg5B: FVEG_08786) in F. verticillioides, the
upstream and downstream flanking sequences of the FVEG_07284
and FVEG_08786 were amplified. The primer pairs were shown in
Table 2.
The resulting PCR products were cloned into the plasmid
pCX62 (Zhao et al., 2004) and results in knockout construct
pCX62-∆Fv07284 and pCX62-∆Fv08786, in which the PCR prod-
ucts were ligated with the hygromycin phosphotransferase (hph)
gene. Then, the deletion cassette was transformed into F. verticil-
lioides 7600 and resulted in deletion mutants. Fungal transforma-
tion followed the protocol reported by Miller et al. (1985), with
minor modification as described by Li et al. (2006).
RESULTS
TRANSCRIPTIONAL RESPONSES TO KETOCONAZOLE STRESS BY
GENES INVOLVED IN ERGOSTEROL BIOSYNTHESIS
Genome-wide transcriptional responses to ketoconazole treat-
ment from two independent experiments were analyzed by DGE
method. For genes involved in ergosterol biosynthesis, seven were
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Table 2 | Primer pairs used for knockout of erg5 homolog gene in F. verticillioides.
Primers Sequence (5′→3′) Product size (bp) Amplified region
Fv07284(p)F-XhoI CCGCTCGAGCACCCGATGAACTCGCCAATA 1859 FVEG_07284 5′ flanking region
Fv07284(p)R-EcoRI CGGAATTCATCATACGCAACGCAAAGAGC
Fv07284(3)F-BamHI CGGGATCCATGATGGGAAAGCGAGTTGA 1717 FVEG_07284 3′ flanking region
Fv07284(3)R-XbaI GCTCTAGAGCTGACAGCGACCAGTAGGA
Fv08786(p)F-KpnI GCGGTACCCGAGGATGATTGCTTGGTGAG 1455 FVEG_08786 5′ flanking region
Fv08786(p)R-EcoRI CGGAATTCCATGCTGGGTCTAGTTGAGGG
Fv08786(3)F-XbaI GCTCTAGAGGGGCAAGGTGTTTGTGAATA 1797 FVEG_08786 3′ flanking region
Fv08786(3)R-XbaI GCTCTAGAAATGCCACTGAGTTCGGATG
Table 3 |Transcriptional response to ketoconazole stress by genes involved in ergosterol biosynthesis in N. crassa wild type.












NCU08280 erg1 Squalene epoxidase 78.1 34.6 0.44 16.1 27.4 1.70
NCU04156 erg2 Sterol biosynthesis 107.1 327.7 3.06 26.8 296.4 11.07
NCU06207 erg3 C-5 sterol desaturase 1000.3 767.0 0.77 639.5 999.0 1.56
NCU01333 erg4 C-24 reductase 1.4 0.6 0.42 1.4 2.0 1.36
NCU05278 erg5 C-22 sterol desaturase 67.4 308.9 4.58 83.5 174.6 2.09
NCU03006 erg6 C-24 sterol methyltransferase 23.8 791.5 33.20 19.3 174.6 9.06
NCU01119 erg7 Oxidosqualene:lanosterol cyclase/lanosterol
synthase
34.0 11.3 0.33 23.0 4.5 0.19
NCU08671 erg8 Phosphomevalonate kinase 24.7 8.7 0.35 26.5 10.6 0.40
NCU06054 erg9 Squalene synthetase 21.1 14.7 0.70 10.1 14.6 1.44
NCU02571 erg10 Acetoacetyl-CoA thiolase 181.6 178.8 0.98 323.8 103.8 0.32
NCU02624 erg11 Cytochrome P450 lanosterol 14α-Demethylase 110.1 812.0 7.37 69.1 676.7 9.80
NCU03633 erg12 Mevalonate kinase 70.1 90.6 1.29 21.6 77.5 3.59
NCU03922 erg13 Hydroxymethylglutaryl-coenzyme A synthase 117.0 47.3 0.40 227.4 35.0 0.15
NCU11381 erg19 Mevalonate pyrophosphate decarboxylase 38.6 21.1 0.55 49.5 18.2 0.37
NCU01175 erg20 Polyprenyl synthetase 188.5 81.1 0.43 116.0 50.9 0.44
NCU08762 erg24 Sterol C-14 reductase 7.1 11.8 1.66 9.2 34.7 3.77
NCU06402 erg25 C-4 methyl sterol oxidase 2512.8 5111.7 2.03 2894.3 5348.9 1.85
NCU02693 erg26 C-3 sterol dehydrogenase 57.0 63.2 1.11 81.5 48.4 0.59
NCU05991 erg27 3-Keto sterol reductase 3.0 4.6 1.53 0.6 1.7 2.90
NCU04461 erg28 Endoplasmic reticulum membrane protein 67.7 28.9 0.43 30.2 33.3 1.10
NCU04144 are2 Acyl-CoA:sterol acyltransferase 1.4 1.4 1.05 0.6 0.1 0.17
NCU00712 hmg1/hmg2 Hydroxymethylglutaryl-coenzyme A reductase 14.8 8.1 0.55 9.8 10.1 1.03
NCU07719 idi1 Isopentenyl diphosphate isomerase 59.2 15.6 0.26 39.4 37.5 0.95
NCU08139 mvd1 Diphosphomevalonate decarboxylase 0 0 – 0 0 –
wt1 and wt(k)1 represent the first batch samples, wt2 and wt(k)2 represent the second batch samples; wt: wild type; wt(k): wild type treated with ketoconazole.
consistently upregulated while four consistently downregulated
upon ketoconazole treatment in two independent experiments
(Table 3). The most dramatically upregulated genes were erg11
(NCU2624), erg6 (NCU03006), erg2 (NCU04156), and erg5
(NCU05278), which were consistently increased upon keto-
conazole treatment by at least three folds in two indepen-
dent experiments. The consistently downregulated genes include
erg7 (NCU01119), erg8 (NCU08671), erg13 (NCU03922), and
erg20 (NCU11381). However, the transcriptional changes in these
downregulated genes were less dramatic than those in erg11, erg6,
erg2, and erg5. None of them had a transcriptional change higher
than three folds.
DELETION OF erg5 INCREASES AZOLE SUSCEPTIBILITY IN N. CRASSA
Six ketoconazole-responsive genes involved in ergosterol syn-
thesis have the knockout mutants available in Fungal Genetics
Stock Center. All these genes are ketoconazole-upregulated genes,
including erg2, erg3, erg5, erg6, erg24, and erg25. On the solid
medium without antifungal drugs, all deletion mutants had the
growth rates similar to the wild-type strain and no obvious defect
was observed in their asexual and sexual reproduction (the data
not shown)2. Drug sensitivity test showed that the deletion of only
2http://www.broadinstitute.org/annotation/genome/neurospora/Phenotypes.html
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erg5 altered the sensitivity to azoles. On agar plates, all three tested
azoles, including ketoconazole, itraconazole, and fluconazole, had
greater inhibition to the erg5 mutants than the wild-type strain
(Figure 1). MIC analysis in the liquid medium showed that MIC
values of the ERG5 mutants for ketoconazole, itraconazole, and
fluconazole were only 60, 50, and 40% of that of the wild-type
strain, respectively (Table 4).
DELETION OF erg5 DOES NOT CAUSE ACCUMULATION OF
14α-METHYLATED STEROLS DURING KETOCONAZOLE STRESS IN
N. CRASSA
ERG5 catalyzes the biosynthesis of ergosta 5,7,22,24(28)-trienol,
a direct precursor for ergosterol biosynthesis. ERG5 mutations
caused accumulation of ergosta 5,7,24(28)-trienol and ergosta 5,7-
dienol in S. cerevisiae ERG5 deletion mutant (Barton et al., 1974;
Skaggs et al., 1996). Thus, it is possible that the erg5 mutant might
accumulate more toxic 14α-methylated sterols than the wild-type
strain. To test this possibility, a comparative analysis of sterol pro-
files between the erg5 mutant and the wild type was performed by
HPLC-MS. Our results showed that, in the normal liquid medium
without ketoconazole, the erg5 mutant produced more ergosta
5,7-dienol than the wild-type strain. As expected, ergosterol in the
erg5 mutant was almost undetectable (Figure 2). When treated
with ketoconazole, 4,4-dimethyl-ergosta 8,14,24(28)-trienol, the
direct product catalyzed by ERG11 (lanosterol 14α-methylase),
was reduced in the wild-type strain and the erg5 mutant at the
similar level. Ketoconazole treatment greatly increased levels of
14α-methylated sterols, such as eburicol and 14α-methyl-ergosta-
8,24(28)-dien-3β, 6α-diol, in both the wild-type strain and the erg5
mutant (Figure 2). However, the levels of these compounds were
similar between the wild-type strain and the erg5 mutant, suggest-
ing that the azole-hypersensitive phenotype in the erg5 mutant is
not due to over-accumulation of 14α-methylated sterols.
ERG5 HOMOLOGS ARE HIGHLY CONSERVED IN FUNGAL KINGDOM
To gain an insight into the sequence conservation and phy-
logenic relationship of ERG5 homologs in fungi, Blast and
phylogenetic analysis were conducted. Blast analysis revealed that
ERG5 homologs are high conserved in amino acid sequences.
Phylogenetic analysis with amino acid sequences of 27 ERG5
homologs (E value= 0; Alignment coverage>90%; sequence sim-
ilarity>76%) from 3 yeast fungal species (C. albicans, S. cerevisiae,
Schizosaccharomyces pombe) and 16 filamentous fungal species
showed that all ERG5 homologs were clustered into 2 big clades
(Figure 3). The ERG5 homologs from yeast fungal species were
distributed in the first clade (clade I), which represents the most
ancestral group, while those from filamentous fungal species were
located in the second clade (clade II).
As shown in Figure 3, ERG5 in filamentous fungi can be further
categorized into two classes based on their phylogenic relationship,
namely Type IIA and Type IIB, respectively. N. crassa, N. fischeri, A.
niger, A. nidulans, T. reesei, M. grisea, and V. albo-atrum have only
one erg5 gene, all in Type IIA. A. fumigatus, A. oryzae, and A. clava-
tus and all examined Fusarium species have two erg5 genes, one in
Type IIA and the other in Type IIB. A. terreus is the only species
that has three erg5 genes, two in Type IIA and one in Type IIB.
Similar to ERG5, multiple ERG3 and ERG11 homologs were also
found in Aspergillus and Fusarium species (Ferreira et al., 2005;
Liu et al., 2010; Becher et al., 2011).
DELETION OF erg5 INCREASES AZOLE SUSCEPTIBILITY IN
F. VERTICILLIOIDES
To see if ERG5 in other filamentous fungi also mediate azole
sensitivity, gene knockout mutants for Type IIA erg5 gene erg5A
(FVEG_07284) and for Type IIB erg5 gene erg5B (FVEG_08786),
in the pathogenic fungus F. verticillioides were generated. As shown
in Figure 4, on the medium without drug, the growth rates of
the erg5 deletion mutants were similar to that of the wild-type
strain and no defect in conidiation was observed in the mutants.
When inoculated on the medium with 0.5µg/ml ketoconazole,
both erg5A and erg5B mutant displayed greater growth inhibi-
tion than the wild-type strain, indicating the ERG5 homologs
have similar roles in azole resistance among different fungal
species.
FIGURE 1 | Drug susceptibility analysis of the erg5 knockout
mutant of N. crassa. Two microliters of conidial suspension (1× 104)
conidia/ml were inoculated on the center of plates (Φ= 9 cm) with or
without antifungal drugs, then incubated at 28˚C for 66 h. Each test
had three replicates and the experiment was independently repeated
twice.
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DISCUSSION
Although transcriptional responses by genes of sterol biosynthesis
to azole stress have been observed in many fungal species (Bam-
mert and Fostel, 2000; De Backer et al., 2001; Agarwal et al., 2003;
Liu et al., 2005, 2010; da Silva Ferreira et al., 2006; Yu et al.,
2007; Becher et al., 2011; Florio et al., 2011), it is still mysteri-
ous about the biological significance of transcriptional activation
for most of these genes. Taking advantage of the availability of
knockout mutants of N. crassa, we analyzed the contributions
of six ketoconazole-responsive genes in ergosterol biosynthesis,










WT 2.5±0 31.25±0 5.0±0
∆erg5 (a) 1.5±0 12.5±0 2.5±0
∆erg5 (A) 1.5±0 12.5±0 2.5±0
including erg2, erg3, erg5, erg6, erg24, and erg25, to azole resistance,
and demonstrated that deletion of erg5, but not other ergos-
terol genes, could make N. crassa more susceptible to antifungal
azoles. Since the deletion of erg5 should result in an effect oppo-
site to its overexpression, transcriptional increase of erg5 upon
azole stress might positively contribute to the azole resistance.
As erg5 deletion consistently resulted in azole hypersensitivity in
both N. crassa and F. verticillioides, strategies that either silenc-
ing the expression of erg5 or disrupting C-22 sterol desaturase
(ERG5) activity can make fungal pathogens more susceptible
to antifungal azoles. ERG5, thus, can be a promising target for
antifungal drug design or fungal disease management in crops.
Although no alteration in azole sensitivity was observed in the
mutants for the rest of ergosterol biosynthesis genes, their tran-
scriptional increases during azole treatment suggest that these
genes are involved in the adaptation to azole stress. Their contribu-
tions to azole resistance might be able to be detected by combined
mutation of multiple genes. Nevertheless, erg5 is the most impor-
tant contributor to azole resistance among these azole-responsive
genes.
FIGURE 2 | HPLC-MS chromatogram of sterol extracts (A) and schematic representation of the ergosterol biosynthetic pathway (B) in N. crassa.
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FIGURE 3 | Phylogenic analysis of fungal ERG5 homologs.
Predicted REG5 proteins from 19 fungal species were aligned and a
condensed neighbor-joining (NJ) tree was constructed with cut-off
bootstrap values of 50% obtained from 1000 replicates using MEGA
5 software (Tamura et al., 2011). (Cal, C. albicans; Sce, S. cerevisiae;
Spo, S. pombe; Ncr, N. crassa; Afu, A. fumigatus; Afl, A. flavus; Anid,
A. nidulans; Anig, A. niger ; Acl, A. clavatus; Ate, A. terreus; Aor, A.
oryzae; Nfi, N. fischeri ; Fve, F. verticillioides; Fox, F. oxysporum; Fgr, F.
graminearum; Tru, T. rubrum; Val, V. albo-atrum; Tre, T. reesei ; Mag, M.
grisea).
Membrane sterols regulate membrane fluidity, permeability,
the activity of membrane-bound enzymes and growth rate (Skaggs
et al., 1996). In S. cerevisiae, genes involved in early steps of
ergosterol biosynthesis, such as ERG9 (squalene synthase), ERG1
(squalene epoxidase), ERG7 (lanosterol synthase), ERG11 (lanos-
terol 14α demethylase), and ERG24 (C-14 reductase), are essential,
while genes participating the late steps of ergosterol biosynthe-
sis, such as ERG2, ERG3, ERG6, ERG5, ERG25, and ERG4, are
not essential (Fryberg et al., 1973; Lees et al., 1995). In N. crassa,
viable homokaryotic mutants for only these non-essential genes
were generated. Thus, the end-product ergosterol is not neces-
sary for fungal survival. When ergosterol is absent, other sterol
intermediates might function as substitutes of ergosterol. Sim-
ilar to previous observation in S. cerevisiae (Kelly et al., 1995),
our data showed that disruption of lanosterol 14α-demethylase
by ketoconazole reduced 4,4-dimethyl-ergosta 8,14,24(28)-trienol
biosynthesis and accumulated 14αmethylated sterols such as 14α-
methyl-ergosta-8,24(28)-dien-3,6-diol. ERG5 catalyzes the chem-
ical reaction downstream to 4,4-dimethyl-ergosta 8,14,24(28)-
trienol biosynthesis. As shown in Figure 2, deletion of erg5
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy May 2013 | Volume 4 | Article 127 | 6
Sun et al. ERG5 mediates azole sensitivity
FIGURE 4 | Drug susceptibility analysis of the erg5A (FVEG_07284) and
erg5B (FVEG_08786) knockout mutants of F. verticillioides. Two
microliters of conidial suspensions with different concentration (1×105,
1×104, 1×103, or 1×102 conidia/ml, respectively) were inoculated on the
plates (Φ=9 cm) with or without antifungal drugs, and incubated at 28˚C
for 72 h. Each test had three replicates and the experiment was
independently repeated twice.
is not likely to reduce the biosynthesis of 4,4-dimethyl-ergosta
8,14,24(28)-trienol under ketoconazole stress. Therefore, the
azole-hypersensitive phenotype in erg5 mutants is not related to
the biosynthesis of 4,4-dimethyl-ergosta 8,14,24(28)-trienol. In
addition, deletion of erg5 did not lead an increase in accumu-
lation of 14α-methylated sterols upon ketoconazole stress. Thus,
over-accumulation of 14α-methylated sterols is also not a possible
cause to the azole-hypersensitive phenotype in erg5 mutants. An
in vitro experiment has shown that ketoconazole can bind to ERG5
(CYP61) of S. cerevisiae with an affinity similar to that of ERG11
(Kelly et al., 1997). Binding of azole to ERG5 might reduce the con-
centration of azoles attacking ERG11, providing a protective buffer
to ERG11. If it is true, removal of erg5 will increase azole sensi-
tivity. In addition, when ergosterol is absent, localization of some
membrane proteins, such as azole pumps, might be affected and
make cells accumulate more azoles. The real mechanism requires
further investigation.
In summary, this study reported azole sensitivities of knock-
out mutants for 6 azole-responsive genes involved in ergosterol
biosynthesis and demonstrated that deletion of erg5 increase azole
sensitivity in both N. crassa and F. verticillioides. Our findings
provide a new insight into in the mechanism of azole resistance.
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